4-carbamoylimidazolium 5-olate has been researched along with Experimental Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, M; Inaba, M; Sakurai, Y; Tsukagoshi, S | 1 |
| Fukui, M; Inaba, M; Sakurai, Y; Tsukagoshi, S; Yoshida, N | 1 |
2 other study(ies) available for 4-carbamoylimidazolium 5-olate and Experimental Leukemia
| Article | Year |
|---|---|
New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.
Topics: Adenine Phosphoribosyltransferase; Animals; Antineoplastic Agents; Cells, Cultured; Chromatography, Thin Layer; Enzyme Activation; Imidazoles; IMP Dehydrogenase; Inosine Nucleotides; Leukemia L5178; Leukemia, Experimental; Mice; Pentosyltransferases; Purines | 1982 |
Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Guanosine Monophosphate; Hypoxanthine Phosphoribosyltransferase; Imidazoles; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mercaptopurine; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Purines | 1982 |